Cost minimisation analysis of fingolimod vs natalizumab as a second line of treatment for relapsing-remitting multiple sclerosis
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Antonio García-Ruiz Carlos Crespo |
| Publication date | October 23, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |